Pharmacology · Antidiabetic Drugs (Oral Hypoglycemics, Insulins)

The incretin effect refers to the greater insulin secretory response to oral glucose versus IV glucose at matching plasma glucose levels. Which receptor does GLP-1 activate to stimulate insulin secretion in a glucose-dependent manner?

  • A GLP-1 receptor (GLP-1R) — a Gs-coupled GPCR activating adenylyl cyclase, raising cAMP
  • B GLUT-2 transporter acting as an intracellular signal transducer
  • C Insulin receptor beta subunit tyrosine kinase
  • D Sulfonylurea receptor (SUR-1) on ATP-sensitive K+ channels
Correct answer: A. GLP-1 receptor (GLP-1R) — a Gs-coupled GPCR activating adenylyl cyclase, raising cAMP

Explanation

GLP-1 binds the GLP-1 receptor, a Gs-coupled GPCR on pancreatic beta cells. This activates adenylyl cyclase, raising intracellular cAMP, which potentiates glucose-stimulated insulin secretion. The key feature is glucose-dependence — GLP-1 receptor activation only stimulates insulin when blood glucose is elevated, greatly reducing hypoglycemia risk compared to sulfonylureas. GLP-1 receptor agonists (exenatide, liraglutide, semaglutide) mimic this effect.

Reference: KD Tripathi, Essentials of Medical Pharmacology, 8th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 23,000+ MCQs.

Start free → Log in

More Antidiabetic Drugs (Oral Hypoglycemics, Insulins) MCQs

See all Antidiabetic Drugs (Oral Hypoglycemics, Insulins) MCQs →